Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patients.

Breast cancer research and treatment - 1 Feb 2021

Lattimore Vanessa, Parsons Michael T, Spurdle Amanda B, Pearson John, Lehnert Klaus, Sullivan Jan, Lintott Caroline, Bawden Suzannah, Morrin Helen, Robinson Bridget, Walker Logan

Abstract excerpt

BACKGROUND: Diagnostic screening for pathogenic variants in breast cancer susceptibility genes, including BRCA1, BRCA2, PALB2, PTEN and TP53, may be offered to New Zealanders from suspected high-risk breast (and ovarian) cancer families. However, it is unknown how many high-risk pathogenic variant carriers in New Zealand are not offered genetic screening using existing triage tools and guidelines for breast (and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Genes, BRCA2

Share to Genetic Testing

Share to Germ-Line Mutation

Share to Heterozygote

Share to New Zealand

Source

Open in PubMed Open full text

Identifiers

PMID: 33113089
DOI: 10.1007/s10549-020-05986-8
PMCID: PMC7921023

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patients.PMID 33113089Read ↗

Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres.Semantic proximity Read ↗

Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centresSemantic proximity Read ↗

Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 PatientsSemantic proximity Read ↗

Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls.Semantic proximity Read ↗

Genetic, Surgical and Oncological Approach to Breast Cancer, with BRCA1, BRCA2, CDH1, PALB2, PTEN and TP53 VariantsSemantic proximity Read ↗

Beyond tumors: uninvolved breast tissue of breast cancer patients with adverse prognoses is enriched for pathogenic PIK3CA and TP53 post-zygotic variants.Semantic proximity Read ↗

Radiographic Surveillance of Patients with Non-BRCA1/2 Pathogenic Variants.Semantic proximity Read ↗

Prevalence of pathogenic variants in actionable genes in advanced ovarian cancer: a next-generation sequencing analysis of a nationwide registry study.Semantic proximity Read ↗

Putative breast cancer risk variants from populations of South Asian ancestry are under-represented in public variant classification databasesSemantic proximity Read ↗

Implementation and Audit of Mainstream Genetic Testing Within a High-Volume UK Breast Unit for Pathogenic Variations Associated With Breast Cancer Using the R208 and R444.1 National Test Directory Criterion.Semantic proximity Read ↗

Beyond Tumors: Reduced Survival Linked to Pathogenic PIK3CA and TP53 Post-Zygotic Variants in the Uninvolved Breast Tissue of Recurrent Cancer PatientsSemantic proximity Read ↗

Low BRCA1 and BRCA2 Germline Mutation Rates in a French-Canadian Population with a Diagnosis of Epithelial Tubo-Ovarian Carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.